Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
35.87
+1.14 (3.28%)
Jun 30, 2026, 11:23 AM EDT - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $25.8 billion as of June 30, 2026. Its market cap has increased by 235.27% in one year.
Market Cap
25.80B
Enterprise Value
20.80B
1-Year Change
235.27%
Ranking
Category
Stock Price
$35.87
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $25.80B, an increase of 4,737.15%. That is a compound annual growth rate of 100.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 25.80B | 70.95% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 40.95B |
| Alnylam Pharmaceuticals | 39.19B |
| Royalty Pharma | 32.87B |
| BeOne Medicines AG | 32.24B |
| Moderna | 27.66B |
| BioNTech SE | 23.84B |
| Incyte | 22.91B |
| Insmed | 22.70B |